Production of biologically active recombinant human factor H in Physcomitrella
about
Atypical hemolytic uremic syndromeComplement inhibitors for age-related macular degenerationComplement inhibitors for age-related macular degenerationComplement in age-related macular degeneration: a focus on functionMembranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusionProduction of biologically active complement factor H in therapeutically useful quantitiesReannotation and extended community resources for the genome of the non-seed plant Physcomitrella patens provide insights into the evolution of plant gene structures and functionsDisease-associated N-terminal complement factor H mutations perturb cofactor and decay-accelerating activities.Anti-complement-factor H-associated glomerulopathies.Moss-Produced, Glycosylation-Optimized Human Factor H for Therapeutic Application in Complement Disorders.Dense deposit disease.Moss-made pharmaceuticals: from bench to bedside.Identification of Targets and Interaction Partners of Arginyl-tRNA Protein Transferase in the Moss Physcomitrella patens.High contents of very long-chain polyunsaturated fatty acids in different moss species.Glycoprotein production in moss bioreactors.The potential of Physcomitrella patens as a platform for the production of plant-based vaccines.Factor h: a complement regulator in health and disease, and a mediator of cellular interactions.Glyco-engineering for biopharmaceutical production in moss bioreactors.Stable heterologous expression of biologically active terpenoids in green plant cellsBiologic agents in the treatment of glomerulonephritides.Implications of plant glycans in the development of innovative vaccines.Protection of host cells by complement regulators.Heterologous protein production in plant systems.A red light-controlled synthetic gene expression switch for plant systems.Disease-linked mutations in factor H reveal pivotal role of cofactor activity in self-surface-selective regulation of complement activation.Stable Production of the Antimalarial Drug Artemisinin in the Moss Physcomitrella patens.Towards designer organelles by subverting the peroxisomal import pathwayAn Env-derived multi-epitope HIV chimeric protein produced in the moss Physcomitrella patens is immunogenic in mice.A gene responsible for prolyl-hydroxylation of moss-produced recombinant human erythropoietin.An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathy.Moss-based production of asialo-erythropoietin devoid of Lewis A and other plant-typical carbohydrate determinants.A Review of Biotechnological Artemisinin Production in Plants.A single homeobox gene triggers phase transition, embryogenesis and asexual reproduction.RecQ helicases function in development, DNA repair, and gene targeting in Physcomitrella patens.An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy.
P2860
Q21202864-5C63581F-CDF6-4886-835A-216022F186D3Q24201117-995F2A06-D9BE-4A71-A532-E7C9EDDA170EQ24234636-1AA558C4-DA11-4683-A2DB-66D8A3D11F86Q24635874-69D3F010-6B4D-4A41-90E7-8BEF3F63F24DQ27008508-D3547099-C4DD-415F-8A61-3F7B50EB5F5FQ28300280-26D446F4-6271-4736-9451-D2C8A6EBBC21Q28690977-A6C888E5-3742-4429-A25A-3DECA4B38699Q33393852-62ECEBF3-6145-4BE2-A67C-C13D9A250BB4Q33434103-5F2A2304-DBE1-43B7-A000-1AC4C9F83DBEQ33437488-71C65A9F-37CA-48A1-A3CB-644D379022B5Q35124165-AB0A7FE2-9E58-4C18-B7C5-6690D40DE80FQ36530505-00DFD255-0E0A-45C5-9A87-81DB36BA0483Q37372346-CC7BC27F-95FD-40BA-BE4C-43DB9DD053A6Q37539197-A017F541-D27F-4D34-BE1D-20762E6FFE39Q37940883-86003AE0-E661-4320-86D3-45CF8640181DQ38176986-29B3C0B0-ED71-4BC6-BC23-D117BA0B9635Q38223669-F64AA486-E6B5-4EA9-B6BE-E8E74B2BB87BQ38234961-EFFAFCF4-12D1-4B20-B861-F7F5E60BFFD4Q38411000-958B4242-7559-493A-8923-7B519003B94BQ38514894-A6E54F2D-89C5-44E1-A48F-5EF25DA2B998Q38738762-80D46330-691D-45B0-B156-6B5BFADEC89BQ38991019-06215117-94B2-40DA-A2C0-0A106C60828AQ38992414-2458C05E-AD3D-4B05-85D2-51D14E8493EAQ39262491-6D5296B9-3C80-48DE-87EE-57ACF35FE1CDQ41377869-7E0C5E41-0C4D-4657-995E-D69C99C7B07AQ41436278-95472CC7-AB86-4581-B87B-9B426B720A37Q41628341-CEBEA31C-5A39-467D-AF61-7573505F88B5Q41725365-F0EA8A3D-1B5E-4C5B-A6E7-7E847126BA48Q42044055-6B7DB57D-71D4-4F33-BFC4-DEC0E3F0FF7EQ42625961-D14C01D6-3871-477F-8C1C-FF9C4FBBA2B8Q45716164-552E9D33-F30D-4780-B3CA-77F17693503CQ46253594-4454B1D5-56A4-48EF-8331-16757A70C626Q48216110-DD4CBDDF-D361-4908-9CE6-7CCE6AE7050AQ50420467-449A3617-833A-4CE5-8177-71D963A38D29Q51730313-FC0EBEB5-7C79-4BB9-8C30-F17C800D6BE7
P2860
Production of biologically active recombinant human factor H in Physcomitrella
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Production of biologically active recombinant human factor H in Physcomitrella
@ast
Production of biologically active recombinant human factor H in Physcomitrella
@en
Production of biologically active recombinant human factor H in Physcomitrella
@nl
type
label
Production of biologically active recombinant human factor H in Physcomitrella
@ast
Production of biologically active recombinant human factor H in Physcomitrella
@en
Production of biologically active recombinant human factor H in Physcomitrella
@nl
prefLabel
Production of biologically active recombinant human factor H in Physcomitrella
@ast
Production of biologically active recombinant human factor H in Physcomitrella
@en
Production of biologically active recombinant human factor H in Physcomitrella
@nl
P2093
P2860
P1476
Production of biologically active recombinant human factor H in Physcomitrella
@en
P2093
Andrea Hartmann
Andreas Schaaf
Andreas Schlosser
Annette Büttner-Mainik
Eva L Decker
Hanna Jérôme
Juliana Parsons
Peter F Zipfel
Ralf Reski
Stephanie Lamer
P2860
P304
P356
10.1111/J.1467-7652.2010.00552.X
P407
P577
2011-04-01T00:00:00Z